First Trust Direct Indexing’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-54,308
Closed -$4.55M 126
2024
Q3
$4.55M Buy
54,308
+8,518
+19% +$671K 0.24% 75
2024
Q2
$3.53M Buy
45,790
+7,284
+19% +$533K 0.22% 84
2024
Q1
$2.64M Buy
38,506
+3,482
+10% +$224K 0.2% 100
2023
Q4
$2.02M Buy
35,024
+2,187
+7% +$117K 0.18% 122
2023
Q3
$1.73M Sell
32,837
-710
-2% -$37.2K 0.2% 115
2023
Q2
$1.81M Buy
33,547
+1,802
+6% +$94.1K 0.2% 110
2023
Q1
$1.59M Buy
31,745
+1,666
+6% +$78.5K 0.19% 121
2022
Q4
$1.39M Buy
30,079
+560
+2% +$24.2K 0.18% 132
2022
Q3
$1.14M Buy
29,519
+1,382
+5% +$55.4K 0.17% 151
2022
Q2
$1.05M Buy
28,137
+518
+2% +$21.1K 0.15% 184
2022
Q1
$1.22M Buy
27,619
+2,235
+9% +$96.9K 0.15% 171
2021
Q4
$1.08M Sell
25,384
-78
-0.3% -$3.28K 0.14% 172
2021
Q3
$1.1M Buy
25,462
+3,886
+18% +$172K 0.16% 153
2021
Q2
$923K Buy
21,576
+4,008
+23% +$169K 0.14% 187
2021
Q1
$679K Buy
17,568
+1,112
+7% +$42.1K 0.18% 163
2020
Q4
$592K Buy
+16,456
New +$593K 0.16% 161

Other funds holding BSX

First Trust Direct Indexing's BSX Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 54,308 shares — an estimated $4.55M sold.

First Trust Direct Indexing first reported a position in BSX in Q4 2020 and held it in 16 quarters. The position peaked at $4.55M in Q3 2024. 1,512 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 54,308 Boston Scientific shares in Q4 2024, an estimated $4.55M.
  • First Trust Direct Indexing first reported a position in Boston Scientific in Q4 2020 and held it in 16 quarters.
  • First Trust Direct Indexing's Boston Scientific position peaked at $4.55M in Q3 2024.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.